Astec Lifesciences (BOM:533138) Total Stockholders Equity : ₹2,347 Mil (As of Mar. 2025)

View and export this data going back to 2009. Start your Free Trial

What is Astec Lifesciences Total Stockholders Equity?

Astec Lifesciences's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ₹2,347 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Astec Lifesciences's Book Value per Share for the quarter that ended in Mar. 2025 was ₹119.70. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Astec Lifesciences's Debt-to-Equity for the quarter that ended in Mar. 2025 was 2.36.

Astec Lifesciences Total Stockholders Equity Historical Data

The historical data trend for Astec Lifesciences's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astec Lifesciences Total Stockholders Equity Chart

Astec Lifesciences Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Total Stockholders Equity

Get a 7-Day Free Trial

3,091.78

3,964.95

4,193.63

3,692.87

2,347.45

Astec Lifesciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															3,692.87	-	2,914.97	-	2,347.45

Astec Lifesciences (BOM:533138) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Astec Lifesciences's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2347.452	-	0)	/	19.611
	=	119.70

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Astec Lifesciences's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2745.441	+	2800)	/	2347.452
	=	2.36

Astec Lifesciences Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Astec Lifesciences's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Astec Lifesciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Astec Lifesciences Ltd (BOM:533138) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ASTEC:India

Address

Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079

Website

https://www.godrejastec.com

Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.

Astec Lifesciences Headlines

No Headlines